BDNF and stroke disorder: A right middle cerebral artery occlusion was performed to establish stroke, following which placebo or BDNF-HA2TAT/AAV (20 μL/day) were administered in the final 10 days of a chronic unpredictable mild stress paradigm, followed by behavioral and biochemical analyses.